| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |